OPTUNE TUMOR TREATING FIELD

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-10-09 for OPTUNE TUMOR TREATING FIELD manufactured by Novocure Ltd..

Event Text Entries

[123492364] Pt involved in clinical trial (this event was reported also by study coordinators to the appropriate regulatory authority) with a parp inhibitor and an alkylating chemotherapy. She was also using optune device (tumor treating field). Her liver enzymes have been gradually increasing over the last 2-3 weeks, but the values spikes yesterday. This lead to her hospitalization. It was not likely to be related to device, as she had been wearing the device significantly longer than taking the study drug and chemotherapy.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5080431
MDR Report Key7951753
Date Received2018-10-09
Date of Report2018-10-04
Date of Event2018-10-03
Date Added to Maude2018-10-10
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameOPTUNE TUMOR TREATING FIELD
Generic NameSTIMULATOR, LOW ELECTRIC FIELD, TUMOR TREATMENT
Product CodeNZK
Date Received2018-10-09
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerNOVOCURE LTD.


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2018-10-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.